![](/images/2013/post-sep.jpg)
EMEA-000347-PIP02-16-M05
P/0209/2023: EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for bilastine (Bilaxten and associated names), (EMEA-000347-PIP02-16-M05)
Reference Number: EMA/236606/2023
![](https://health.einnews.com/tracking/article.gif?aid=725446953§ion=ema.europa.eu&a=9FOh7yqbvRvkvN0z&i=hI_0agLOi3hs1TVQ)
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.